Welcome to our dedicated page for Arkema news (Ticker: ARKAY), a resource for investors and traders seeking the latest updates and insights on Arkema stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Arkema's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Arkema's position in the market.
Arkema reported 2022 sales of €11.5 billion, a 21.3% increase year-on-year, driven by organic growth of 13.6% amid significant raw material inflation. EBITDA reached €2.11 billion, up 22.2%, with an EBITDA margin of 18.3%. Fourth-quarter results showed a decline in EBITDA to €291 million, attributed to destocking and reduced demand, particularly in Europe and China. The company plans to maintain an EBITDA of €1.5 to €1.6 billion in 2023. They propose a dividend of €3.40 per share, up from €3.00. Arkema emphasizes its commitment to sustainability with a 16% reduction in greenhouse gas emissions and aims for 65% of sales to contribute to UN Sustainable Development Goals by 2030.
Arkema has appointed Laurent Tellier as the new Senior Vice-President of Performance Additives, succeeding Marie-Pierre Chevallier. Tellier, with over 20 years of experience at Saint-Gobain, is expected to leverage his expertise to enhance the company’s performance in mature and fast-growing segments.
Arkema aims to transition to a pure player in Specialty Materials by 2024, focusing on its three main segments: Adhesive Solutions, Advanced Materials, and Coating Solutions, which contributed to 85.5% of its €9.5 billion sales in 2021.
Arkema, listed on Euronext Paris under the ticker AKE, reported total shares outstanding at 75,043,514 as of January 31, 2023. The company has a total number of voting rights, including shares held by the company, at 91,658,506. Excluding shares held by the company, the total number of voting rights stands at 91,419,693. This data reflects Arkema's current share structure and provides insights into its governance capabilities.
Arkema has completed a €400 million bond issue with an eight-year maturity and a 3.50% annual coupon, marking a significant move in its financing strategy. This initiative is aimed at extending the average maturity of financing resources and starting the refinancing process for upcoming bond maturities. The company holds a strong credit rating of BBB+ from Standard & Poor’s and Baa1 from Moody’s. With around €9.5 billion in sales reported in 2021 and operations in 55 countries, Arkema is focused on becoming a pure player in Specialty Materials by 2024, emphasizing innovation in materials science.
On December 31, 2022, Arkema reported a total of 75,043,514 shares outstanding, with 91,660,212 total voting rights, including shares held by the company. Excluding treasury shares, the total voting rights stood at 91,429,125. These figures reflect the company's capital structure and shareholder voting potential. The data is crucial for investors interested in ARKAY, potentially impacting voting dynamics and shareholder engagement in corporate decisions.
Arkema announced its share buyback transactions conducted from January 2 to January 6, 2023. During this period, the company repurchased a total of 671 shares at a weighted average price of €84.6889. The buybacks comply with EU regulations, specifically Article 5 §2 of Regulation (EU) No 596/2014. Investors can find more details about these transactions on Arkema's official website.
On 3 January 2023, Arkema finalized the divestment of Febex to Belgian group Prayon. Febex specializes in phosphorus chemistry and reported sales of approximately €30 million in 2021, employing 59 people at its Swiss site. This divestment aligns with Arkema's strategy to streamline its portfolio and focus on becoming a pure player in Specialty Materials by 2024, which accounted for about 85.5% of sales in 2021. The Group reported overall sales of around €9.5 billion in 2021.
Arkema announced share buyback transactions conducted from December 26 to December 30, 2022, in compliance with EU regulations. The total volume of shares repurchased during this period was 7,719, with a weighted average price of €84.7282 per share. These transactions are part of the company's strategy to improve shareholder value through capital returns. For additional information, the details are available on Arkema's investor relations website.
Arkema announced its share buyback transactions from December 19 to December 23, 2022, in compliance with EU regulations. The total number of shares bought back during this period amounted to 28,163, with an average acquisition price of €84.52 per share. The buybacks were executed on the Euronext Paris exchange. This activity aligns with Arkema's strategy to enhance shareholder value.
Arkema (Euronext: AKE) announced share buyback transactions conducted from December 12 to December 16, 2022. The buybacks included a total of 14,118 shares, purchased at a weighted average price of €84.3401. The transactions were executed according to Article 5 §2 of Regulation (EU) No 596/2014. Notably, the details of each day’s transactions were provided, indicating an intention to enhance shareholder value.